Fly News Breaks for April 27, 2015
Apr 27, 2015 | 07:21 EDT
Wedbush downgraded Celladon to Neutral and lowered its price target to $3 from $29 due to the failure of Mydicar to meet the primary and secondary endpoints in CUPID2.
News For CLDN From the Last 2 Days
There are no results for your query CLDN